Intended for healthcare professionals

CARTO PRIME™ Module

CARTO™ 3 System and the CARTO PRIME™ Module offers advancement in 3D mapping technology. From signals to diagnosis, across a wide range of electrophysiology procedures, we are re-framing the future of electrophysiology.

CARTO PRIME™ Module

Clinical evidence

93.3%

Cases successfully identified the mechanism of scar-related atrial tachycardias1

In a prospective multi-center study (n=20), Coherent Mapping cases.

9mm

Average position shift between LAT Hybrid PVC Mapping Location and its associated Standard PVC Mapping Location2

In a prospective multi-center study (n=18), LAT Hybrid cases.

Features & benefits

Coherent Mapping

Coherent Mapping

Coherent Mapping may simplify the diagnosis of scar‐related complex atrial arrhythmia by applying physiological constraints on LAT information. It improves accuracy of ablation site identification.1

Features:

  • Conduction ID
  • Conduction velocity vectors
  • Conduction barrier zones; such as scar, slow conduction and anatomical structures
Parallel Mapping and Map Replay

Parallel Mapping and Map Replay

  • Real-time acquisition: Use Parallel Mapping to create a group up to 4 maps and assign each one a different set of acquisition filters. During continuous acquisition, EA points are acquired to the appropriate map.3
  • Recalculate an existing map: The Map Replay option creates a new map by recalculating an existing map according to different acquisition filters.3
  • Retrospectively acquire points from a specific time in the study: Define a time frame in the CARTOREPLAY™ Module Timeline and acquire points according to the acquisition filters in the current Active Map.3
CARTOFINDER™ Module

CARTOFINDER™ Module

The CARTOFINDER™ Module provides automatic analysis of multiple, simultaneous intracardiac (IC) signals and enables the creation of high density dynamic maps.3

LAT Hybrid

LAT Hybrid

Transient changes in the heart rhythm, such as Premature Ventricular Contraction (PVC), can lead to catheter displacement compared to normal sinus activation. LAT Hybrid maps provide a solution for PVC mapping by creating a hybrid point: the coloring reflects the LAT value during PVC rhythm, and the location corresponds to the location during sinus rhythm.3

Supporting documentation

Webpage

Activation Mapping With Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar-Related Atrial Tachycardias

Webpage

Premature ventricular contractions cause a position shift in 3D mapping systems: analysis, quantification, and correction by hybrid activation mapping

Related products

CARTO ELEVATE™ Module

CARTO ELEVATE™ Module

CARTO™ 3 System V8 brings advanced mapping capabilities with enhanced signal analysis tools, improved substrate characterization and utilization of ultrasound technology.

CARTOSOUND™ FAM Module

CARTOSOUND™ FAM Module

Powered by Artificial Intelligence, the CARTOSOUND™ FAM Module reconstructs the left atrial (LA) anatomy on the CARTO™ 3 System with a few rotations of your ultrasound catheter, eliminating the need for manual contouring.

References

  1.  Anter E et al. Activation Mapping with Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar Related Atrial Tachycardias. Circ Arrhythm Electrophysiol. 2018;11:e006536.
  2. Tom De Potter, Konstantinos Iliodromitis, Tal Bar-On, Etel Silva Garcia, Joris Ector, Premature ventricular contractions cause a position shift in 3D mapping systems: analysis, quantification, and correction by hybrid activation mapping, EP Europace, Volume 22, Issue 4, April 2020, Pages 607–612
  3. CARTO 3 System Instructions for Use. UG-5400-0082H (04A), November 2025.
  4. Steyers III CM et al. Ablation using 3D maps adjusted for spatial displacement of premature ventricular complexes relative to sinus beats: Improving precision by correcting for the shift. J Cardiovasc Electrophysiol. 2019;1–7.

Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions. Caution: US law restricts this device to sale by or on the order of a physician.


The THERMOCOOL SMARTTOUCH™ SF Catheter is indicated for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation (AF) and for drug refractory recurrent symptomatic persistent AF (continuous AF > 7 days but < 1 year), refractory or intolerant to at least 1 Class I or III AAD, when used with the CARTO™ 3 System.


Last Updated on 09/25/2025.


US_ELP_NAVI_201219.1